PDF herunterladen
Semin Thromb Hemost 2013; 39(02): 153-160
DOI: 10.1055/s-0032-1333538
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Evaluation of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia

James N. George
1   Department of Biostatistics and Epidemiology, College of Public Health, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
2   Department of Medicine, College of Medicine, Hematology-Oncology Section, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
,
Roseleen S. Charania
2   Department of Medicine, College of Medicine, Hematology-Oncology Section, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
06. Februar 2013 (online)

   Lizenzen und Reprints

Abstract

When a patient presents with unexpected microangiopathic hemolytic anemia and thrombocytopenia, the diagnosis of thrombotic thrombocytopenic purpura (TTP) is often considered. However, many different disorders, including many different systemic infections and malignancies, can cause thrombotic microangiopathy (TMA), with the clinical features of microangiopathic hemolytic anemia and thrombocytopenia. Other etiologies include severe hypertension, preeclampsia, systemic lupus erythematosus, adverse drug reactions, allogeneic hematopoietic stem cell transplantation, and abnormalities of complement regulation. This article focuses on distinguishing TTP from other etiologies of microangiopathic hemolytic anemia and thrombocytopenia, because consideration of the diagnosis of TTP requires an urgent decision for the initiation of plasma exchange treatment. Awareness of the many etiologies of TMA is essential for the appropriate evaluation of patients presenting with microangiopathic hemolytic anemia and thrombocytopenia and the appropriate diagnosis of TTP.

Keywords

microangiopathic hemolytic anemia - thrombotic thrombocytopenic purpura - thrombotic microangiopathy
 

  • References

  • 1 Symmers WS. Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy). BMJ 1952; 2 (4790) 897-903
    CrossrefPubMedSuche in Google Scholar
  • 2 Brain MC, Dacie JV, Hourihane DO. Microangiopathic haemolytic anaemia: the possible role of vascular lesions in pathogenesis. Br J Haematol 1962; 8: 358-374
    CrossrefPubMedSuche in Google Scholar
  • 3 Rock GA, Shumak KH, Buskard NA , et al. Canadian Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325 (6) 393-397
    CrossrefPubMedSuche in Google Scholar
  • 4 Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine (Baltimore) 1966; 45: 139-159
    CrossrefPubMedSuche in Google Scholar
  • 5 George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 2010; 116 (20) 4060-4069
    CrossrefPubMedSuche in Google Scholar
  • 6 Som S, Deford CC, Kaiser ML , et al. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion 2012; 52 (12) 2525-2532
    CrossrefPubMedSuche in Google Scholar
  • 7 Vesely SK, George JN, Lämmle B , et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003; 102 (1) 60-68
    CrossrefPubMedSuche in Google Scholar
  • 8 Kremer Hovinga JA, Vesely SK, Terrell DR, Lämmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 2010; 115 (8) 1500-1511 , quiz 1662
    CrossrefPubMedSuche in Google Scholar
  • 9 George JN, Chen Q, Deford CC, Al-Nouri ZL. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. J Clin Apher 2012; 27 (6) 302-311
    CrossrefPubMedSuche in Google Scholar
  • 10 Tsai H-M. Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes. J Thromb Haemost 2003; 1 (4) 625-631
    CrossrefPubMedSuche in Google Scholar
  • 11 Bentley MJ, Lehman CM, Blaylock RC, Wilson AR, Rodgers GM. The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange. Transfusion 2010; 50 (8) 1654-1664
    CrossrefPubMedSuche in Google Scholar
  • 12 George JN. Forecasting the future for patients with hereditary TTP. Blood 2012; 120 (2) 243-244
    CrossrefPubMedSuche in Google Scholar
  • 13 Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365 (9464) 1073-1086
    PubMedSuche in Google Scholar
  • 14 Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361 (17) 1676-1687
    CrossrefPubMedSuche in Google Scholar
  • 15 Booth KK, Terrell DR, Vesely SK, George JN. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol 2011; 86 (9) 743-751
    CrossrefPubMedSuche in Google Scholar
  • 16 George JN, Al-Nouri ZL. Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes. Hematology (Am Soc Hematol Educ Program) 2012; 604-609
    PubMedSuche in Google Scholar
  • 17 Kosugi N, Tsurutani Y, Isonishi A, Hori Y, Matsumoto M, Fujimura Y. Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor. Intern Med 2010; 49 (7) 689-693
    CrossrefPubMedSuche in Google Scholar
  • 18 George JN. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 2003; 10 (5) 339-344
    CrossrefPubMedSuche in Google Scholar
  • 19 Vesely SK, Li X, McMinn JR, Terrell DR, George JN. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2004; 44 (8) 1149-1158
    CrossrefPubMedSuche in Google Scholar
  • 20 Robertson MD, Zumberg M. Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature. Am J Hematol 2007; 82 (3) 224-228
    CrossrefPubMedSuche in Google Scholar
  • 21 Swisher KK, Doan JT, Vesely SK , et al. Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura: report of five patients with a systematic review of the literature. Haematologica 2007; 92: 936-943
    CrossrefPubMedSuche in Google Scholar
  • 22 Leaf AN, Laubenstein LJ, Raphael B, Hochster H, Baez L, Karpatkin S. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med 1988; 109 (3) 194-197
    CrossrefPubMedSuche in Google Scholar
  • 23 Gunther K, Garizio D, Nesara P. ADAMTS13 activity and the presence of acquired inhibitors in human immunodeficiency virus-related thrombotic thrombocytopenic purpura. Transfusion 2007; 47 (9) 1710-1716
    CrossrefPubMedSuche in Google Scholar
  • 24 Benjamin M, Terrell DR, Vesely SK , et al. Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis 2009; 48 (8) 1129-1137
    CrossrefPubMedSuche in Google Scholar
  • 25 Brecher ME, Hay SN, Park YA. Is it HIV TTP or HIV-associated thrombotic microangiopathy?. J Clin Apher 2008; 23 (6) 186-190
    CrossrefPubMedSuche in Google Scholar
  • 26 Froehlich-Zahnd R, George JN, Vesely SK , et al. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica 2012; 97 (2) 297-303
    CrossrefPubMedSuche in Google Scholar
  • 27 Karpac CA, Li X, Terrell DR , et al. Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol 2008; 141 (5) 696-707
    CrossrefPubMedSuche in Google Scholar
  • 28 Buchholz U, Bernard H, Werber D , et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med 2011; 365 (19) 1763-1770
    CrossrefPubMedSuche in Google Scholar
  • 29 Karpac CA, Lee A, Kunnel BS, Bamgbola OF, Vesely SK, George JN. Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc 2007; 100 (11) 429-433
    PubMedSuche in Google Scholar
  • 30 George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006; 354 (18) 1927-1935
    CrossrefPubMedSuche in Google Scholar
  • 31 George JN. Systemic malignancies as a cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia. Oncology (Williston Park) 2011; 25 (10) 1-8
    PubMedSuche in Google Scholar
  • 32 Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: a report of 10 cases and a systematic review of the literature. Oncologist 2007; 12: 11-19
    PubMedSuche in Google Scholar
  • 33 Antman KH, Skarin AT, Mayer RJ, Hargreaves HK, Canellos GP. Microangiopathic hemolytic anemia and cancer: a review. Medicine (Baltimore) 1979; 58 (5) 377-384
    PubMedSuche in Google Scholar
  • 34 Francis KK, Kojouri K, George JN. Occult systemic carcinoma masquerading as thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Community Oncol 2005; 2: 339-343
    CrossrefPubMedSuche in Google Scholar
  • 35 Zhang B, Xing C, Yu X, Sun B, Zhao X, Qian J. Renal thrombotic microangiopathies induced by severe hypertension. Hypertens Res 2008; 31 (3) 479-483
    CrossrefPubMedSuche in Google Scholar
  • 36 Boctor FN, Prichard JW. Kidney involvement in thrombotic thrombocytopenic purpura and malignant hypertension. Transfusion 2009; 49 (9) 1783-1784
    CrossrefPubMedSuche in Google Scholar
  • 37 Egan JA, Bandarenko N, Hay SN , et al. Differentiating thrombotic microangiopathies induced by severe hypertension from anemia and thrombocytopenia seen in thrombotic thrombocytopenia purpura. J Clin Apher 2004; 19 (3) 125-129
    CrossrefPubMedSuche in Google Scholar
  • 38 Cooling LL, Gay S, Silver S. Transfusion medicine illustrated: An imPRESsive mimic. Transfusion 2010; 50 (1) 11-12
    CrossrefPubMedSuche in Google Scholar
  • 39 McMinn JR, George JN. Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apher 2001; 16 (4) 202-209
    CrossrefPubMedSuche in Google Scholar
  • 40 George JN, Vesely SK, James JA. Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J 2007; 100 (5) 512-514
    CrossrefPubMedSuche in Google Scholar
  • 41 Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol 2010; 85 (11) 844-847
    CrossrefPubMedSuche in Google Scholar
  • 42 Stroncek DF, Vercellotti GM, Hammerschmidt DE, Christie DJ, Shankar RA, Jacob HS. Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis. Blood 1992; 80 (1) 241-248
    PubMedSuche in Google Scholar
  • 43 Gottschall JL, Elliot W, Lianos E, McFarland JG, Wolfmeyer K, Aster RH. Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity. Blood 1991; 77 (2) 306-310
    PubMedSuche in Google Scholar
  • 44 Gottschall JL, Neahring B, McFarland JG, Wu GG, Weitekamp LA, Aster RH. Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature. Am J Hematol 1994; 47 (4) 283-289
    CrossrefPubMedSuche in Google Scholar
  • 45 Kojouri K, Vesely SK, George JN. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med 2001; 135 (12) 1047-1051
    CrossrefPubMedSuche in Google Scholar
  • 46 Lesesne JB, Rothschild N, Erickson B , et al. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 1989; 7 (6) 781-789
    CrossrefPubMedSuche in Google Scholar
  • 47 Humphreys BD, Sharman JP, Henderson JM , et al. Gemcitabine-associated thrombotic microangiopathy. Cancer 2004; 100 (12) 2664-2670
    CrossrefPubMedSuche in Google Scholar
  • 48 Said T, Al-Otaibi T, Al-Wahaib S , et al. Posttransplantation calcineurin inhibitor-induced hemolytic uremic syndrome: single-center experience. Transplant Proc 2010; 42 (3) 814-816
    CrossrefPubMedSuche in Google Scholar
  • 49 Eremina V, Jefferson JA, Kowalewska J , et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008; 358 (11) 1129-1136
    CrossrefPubMedSuche in Google Scholar
  • 50 Sartelet H, Toupance O, Lorenzato M , et al. Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys. Am J Transplant 2005; 5 (10) 2441-2447
    CrossrefPubMedSuche in Google Scholar
  • 51 Leach JW, Pham T, Diamandidis D, George JN. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T-cell lymphoma (Sezary syndrome): a case report. Am J Hematol 1999; 61 (4) 268-270
    CrossrefPubMedSuche in Google Scholar
  • 52 Elliott MA, Nichols Jr WL, Plumhoff EA , et al. Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review. Mayo Clin Proc 2003; 78 (4) 421-430
    CrossrefPubMedSuche in Google Scholar
  • 53 Siami K, Kojouri K, Swisher KK, Selby GB, George JN, Laszik ZG. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation 2008; 85 (1) 22-28
    CrossrefPubMedSuche in Google Scholar
  • 54 George JN. Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder. Bone Marrow Transplant 2008; 41 (11) 917-918
    CrossrefPubMedSuche in Google Scholar
  • 55 Ho VT, Cutler C, Carter S , et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11 (8) 571-575
    CrossrefPubMedSuche in Google Scholar
  • 56 Ruutu T, Barosi G, Benjamin RJ , et al. European Group for Blood and Marrow Transplantation; European LeukemiaNet. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica 2007; 92 (1) 95-100
    CrossrefPubMedSuche in Google Scholar
  • 57 Nester C, Stewart Z, Myers D , et al. Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2011; 6 (6) 1488-1494
    CrossrefPubMedSuche in Google Scholar